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 Abstract 
The widespread usage of extended spectrum cephalosporins in the 1980s led to the 
emergence of β-lactamases capable of destroying them.  Extended spectrum β-lactamases 
(ESBL) are the most common β-lactamases in some parts of the world and represent a 
pandemic of CTX-M ESBLs.  Work examining the epidemiology and distribution of 
specific genotypes both in the UK and across the world particularly in China and India is 
presented. The faecal carriage by humans and dispersal into the environment is described.  
The environment and release of CTX-M producing Enterobacteriaceae into the 
environment following sewage treatment is reported and that arising from fish and poultry 
production.  The work describes the isolation and characterization of the second most 
important CTX-M genotype (CTX-M-14) and the development of novel methods for the 
characterisation of genotypes.  The publications were important in the recognition of the 
significance of CTX-M and drew attention to the characteristic genotype distribution 
around the world.  The importance of faecal carriage as a dispersion mechanism and the 
association of specific genotypes with ethnic groups was a novel finding.  The work also 
was the first to genotype ESBLs in India identifying that CTXM-15 was the only CTX-M 
genotype carried by one of the world’s largest populations. 
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1.0 Background 
Extended Spectrum Beta Lactamases (ESBLs) in human medicine first came to 
prominence following the introduction of the extended-spectrum cephalosporins 
(cefotaxime, ceftazidime, ceftazidime, ceftriaxone, etc.) in the 1980’s.  The term was 
applied to mutants of the already common plasmid mediated β-lactamases such as SHV 
and TEM.  One of the first detected, which originated in France, was TEM-3 ESBL which 
had been presumed to have been selected in the human host following the introduction 
and use of cefotaxine.  Both of the ‘parent’ genotypes of these β-lactamase genes bla TEM-1 
bla TEM-2 were widely disseminated amongst medically important members of 
Enterobacteriaceae and Acinetobacter spp. and it seemed logical that the extended-
spectrum form of the β-lactamase would become much more widely disseminated 
throughout the world under the selective pressure of the use of third generation 
cephalosporins.  This happened to a degree in that particularly some variants of TEM, 
such as TEM-10, TEM-24 and SHV-12, became widely distributed, particularly amongst 
Klebsiella .spp. in hospital settings, but never reached high levels of prevalence (usually 
<20%).  There also was never a significant spread of these genes into the more general 
environmental and commensal pool of Enterobacteriaceae, even in countries where ESBL 
phenotype rates were reported to be very high, such as in China and India. The initially 
named MEN-1 ESBL from an E.coli isolate characterised in France from a patient in Italy 
(1990) was found to be identical to CTX-M-1 from an E.coli  isolated from a child in 
Germany (1989) (Bauernfeind et al. 1996) The same paper also reported 2 further isolates 
of CTX-M-1 producing E.coli from Germany in 1994, but they were regarded as 
examples of unusual β-lactamases because of their rarity in Europe. In the 1990s in South 
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America the emergence and recognition of CTX-M-2 was seen as much more serious as 
the enzyme was found in Salmonella typhimurium, E.coli, Klebsiella spp.and Proteus 
mirabilis in Argentina and Paraguay (Radice et al. 2002). We now, realise this was a 
turning point in the evolutionary history of β-lactamase in Enterobacteriaceae.  In this 
particular case the gene emerged in Enterobacteriaceae as a result of horizontal gene 
transfer from an environmental bacterium in the rhizosphere. The chromosomal homologs 
of the CTX-M genes in different species of Kluyvera have been mobilised into Klebsiella 
spp and E.coli on different occasions and global locations, which gave rise to 6 
sublineages often referred to as “groups” (CTX-M-1,2,8,9,25 and KLUC named after the 
archetypal enzymes of each group), as show in Figure 1.  The indisputable proof of this 
evolutionary route came from work in Paris by Poirel and Naas that showed that the 
neighbouring sequences of bla CTX-M-2, bla CTX-M-5 and Toho-1 were identical to those in 
Klyvera (Humeniuk et al. 2002). Subsequently work in China revealed that SHV and 
TEM type ESBLs were not the most common but another CTX-M variant, CTX-M-14, 
with smaller numbers of CTX-M-3 (Chanawong et al.,2002 5).  Simultaneously with the 
description of CTX-M-14; CTX-M-15 was described in Paris from six of isolates from 
New Delhi in India.  These two particular genotypes have assumed worldwide dominance 
with reports from studies in India and China showing these to be the dominant CTX-M, 
and in the case of India CTX-M-15 being the only genotype present in the entire country 
(Ensor et al., 2006 9) Hawkey 2008 13).  We now have a position in the world where 
CTX-M is the most dominant ESBL and indeed in some locations is the most dominant β-
lactamase in Gram-negative bacteria. The situation has been likened to a pandemic and it 
is not apparent at what rate in human isolates ESBL carriage will finally stabilize.  CTX-
M ESBL genes are now widely dispersed not only in human gut flora but also that of food 
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animals which has implications for both the colonisation of people and spread via food 
across the globe.  The wider environment, particularly rivers, have been exposed to CTX-
M ESBL producing E.coli and Klebsiella spp via human sewage and animal manure 
creating a further reservoir and route for colonisation/infection of humans.  The 
phylogenetic groups of E.coli carrying CTX-M genes are varied; however the B2 extra-
intestinal pathogenic strains carry CTX-M genes more frequently.  This is particularly true 
of the ST131 lineage which typically carries CTX-M-15 which is the most common 
genotype of CTX-M in the world. The expansion of CTX-M ESBL has driven the use of 
antibiotics that retain activity against them which generally means carbapenems (e.g. 
meropenem, ertapenem etc.)   This selection pressure has given rise to the emergence of a 
whole family of diverse carbapenemases which represent a new major threat to modern 
medicine.  
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Figure 1. Tree diagram showing the similarity among enzymes of the CTX-M linage and clustering of members of different CTX-M groups.  
The tree was constructed with the TREEVIEW program on the basis of amino acid sequence alignment of available sequences of CTX-M and 
cognate proteins from Kluyvera spp. Available at the Lahey Clinic Website (http://ww.lahey.org/Studies/).  Figure after D’Andrea et al (2013) 
IJMM, 303:305-317. 
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2.0 Contextual significance of the publications presented in this thesis 
My research on the CTX-M genetic family of extended spectrum β-lactamases is 
integrated by addressing a number of specific areas which are interrelated. These are used 
as sub-headings to group my publications and explain their significance in relation to 
other publications and the state of knowledge at the time that I wrote the papers. 
My papers that I present for this thesis are referred to in the text and on the reprints at the 
back of the thesis by number (1-33).  That number correlates with the list of publications 
(Section 3.0), the text following in 3.1.  The additional references by other workers cited 
in this review are listed in the reference section 4.0. 
2.1 Molecular evolution, genetic mobility and expression of CTX-M β-lactamases  
My involvement with the CTX-M β-lactamases dates from my first visit to China in 1998 
to run a course on the detection of antibiotic resistant bacteria for the WHO Emerging 
Pathogens Initiative.  I went to Guangzhou in Southern China, in 1998. The course was 
based at the First Municipal Peoples Hospital of Guangzhou.  Dr Jian Hui Xiong had 
carried out a survey of resistance of gram negative bacilli to various antibiotics using 
NCCLS methodology and approved media.  The ESBL production rate was 33% for 
E.coli and 37% for Klebsiella pneumoniae.  I appreciated that this was an exceptional 
finding and these isolates needed molecular characterisation for which facilities were not 
available in China at that time.  I therefore arranged for the isolates to be transported to 
my laboratory and examined in detail. There had only been a single confirmed report of 
SHV-2 in Klebsiella spp. and Enterobacter spp. in 1994 (Cheng 1994) A total of 15 
isolates of Enterobacteriaceae including 8 E.coli and 3 Klebsiella pneumonia were fully 
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characterised.  SHV ESBL genes (SHV-11 & SHV-12) were found in 8 isolates but none 
of the other commonly recognised, at that time, ESBL genes were found using PCR.  I 
thought this may be a rare ESBL gene so in view of the strong cefotaximase activity 
designed a number of consensus PCR primers for various rarer ESBL genes including 
CTX-M.   I was delighted to get product from the PCR primers for CTX-M for 13 of the 
15 isolates. (Chanawong et.al 2002 5). 
Subsequent transfer of plasmids and full sequencing with cloning revealed 3 novel CTX-
M genes for which we were allocated the genotype numbers 13,14 and 15.  Whilst the 
paper was in proof I was contacted by a French microbiologist suggesting that our CTX-
M-15 was identical to CTX-M-9 reported by Sabate and colleagues in Spain.  We had 
carefully checked our sequence and it was one base different to that in in Genbank for 
CTX-M-9.  However, when we rechecked it in Genbank it appeared that the entry had 
subsequently been re-edited to the same sequence that we had, hence we amended our 
paper to refer to CTX-M-9 rather than CTX-M-15.  Ironically the number went back into 
the pool and was allocated to a bla CTX-M gene found in some Indian isolates characterised 
in Paris which is now recognised as the most common bla CTX-M worldwide.  
Whilst we were characterising these isolates a paper appeared from the Ron Jones group 
looking at ESBL Klebsiella spp. from Beijing but only using isoelectric focusing on the β-
lactamases (Shen et al. 2001). They found 4/14 isolates to produce a β-lactamase with a PI 
of 8.2 which is remarkably close to the value of 8.1 which we found for CTX-M-14 and 
CTX-M-13.  I am sure these isolates reported by Shen carried CTX-M-14 (we only found 
CTX-M-13 in a single isolate).  Our identification of CTX-M-14 was the first description 
of what subsequently became the world’s second most common CTX-M ESBL.  Most 
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importantly we identified ISEcp1as the likely mobilising element for blaCTX-M-14 as I knew 
it had been reported by P.D. Stapleton in an ICAAC abstract in 1999 as mobilising the 
chromosal AmpC to become CMY-4 plasmid mediated AmpC β-lactamase.  Our Southern 
blots clearly showed the presence of the bla CTX-M-14 gene on both the chromosome and 
plasmids.  We also demonstrated the migration (in some strains) to the chromosome of 
recipient strains following conjugation.  This was the first description of the mobilisation 
of bla CTX-M between replicons. It was the first study revealing the extent of the problem of 
ESBLs in China and identifying CTX-M-14 as the most important enzyme.  I wrote a 
concluding sentence in the paper which turned out to be prophetic, “The ease with which 
such bacteria can be isolated should be a cause for grave concern and indicates the need 
for more detailed surveillance and epidemiological surveys in this region, which has 
increasing contact with the rest of the world.” 
On moving to Birmingham in 2002 I was approached by Dr. Nigel Brenwald of City 
Hospital to characterise a collection of Klebsiella pnemonaie that had been causing what 
transpired to be the first nosocomial outbreak of CTX-M producing Enterobacteriaceae in 
the UK (Brenwald et al 2003 4).  The Open Reading Frame of the bla CTX-M-8  gene had 
99% of homology with blaCTX-8  .genotype group.  I initiated a detailed study of our gene 
which was designated bla CTX-M-26 and was sent an example of CTX-M-25 from Canada by 
Dr. Mike Mulvey to characterise at the same time (Munday et al. 2004a 22). We identified 
ISEcp1 as the mobilising element in bla CTX-M-26 which lacked the ceftazidimase activity 
of CTX-M-25 and I identified the amino acid substitution probably responsible for this 
substrate profile change. 
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There has been considerable debate on the susceptibility of strains of Enterobacteriaciae 
producing difference genotypes of CTX-M β-lactamase to β-lactamase inhibitors 
(BL/BLI).  The level of expression of the CTX-M β-lactamase would be expected to cause 
variation in susceptibility to BL/BLIs.  Prof. Nancy Hanson made an observation that 
E.coli from urine samples had elevated levels of mRNA if they produced CTX-M-15 
compared to CTX-M-14 production. She asked me to collaborate to study my global 
collection of CTX-M-15 and 14 producers and look at protein levels in both genotypes.  
Surprisingly we saw a good correlation between mRNA transcripts and protein production 
for CTX-M-14 but not in the case of CTX-M-15 (Geyer et al 2016 JAC 71:607-16 12).  
Our observation suggests that reduced susceptibility to Beta Lactam/Beta Lactamase 
Inhibitor combinations is due to an as yet unrecognised mechanism(s) for CTX-M-15.  
This finding may well be important in the future as we will rely on new BL/BLI 
combinations to treat MRGNB such as infections as ceftazidime/avibactam is not only 
active against carbapenemases but also CTX-M ESBL producers. 
2.2 Detection and genotyping of CTX-M ESBLS 
During the course of strain typing and genotyping by PCR based sequencing of the first 
UK outbreak of CTX-M ESBL producing Enterobacteriaceae susceptibility studies I 
suggested that cefpodoxime would be the best β-lactam substrate to detect genotypes with 
both cefotaximase (CTX-M-14 9 etc.) and those with additional ceftazidimase activity 
(Brenwald et al.2003 4). This was the first report of the use of cefpodoxime to detect 
CTX-M β-lactamases and became widely used in the UK, leading to one of the best ESBL 
surveillance situations in any European country.   
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In order to undertake large scale surveillance I felt we needed a fast and cheap method for 
the detection and placing of CTX-M ESBLs in the appropriate genotype groups.  The 
biggest obstacle was identifying consensus sequences to design PCR primers to give both 
specificity for the different genotype groups whilst retaining sensitivity to detect the full 
range of individual genotypes.  Working with Dr Xu Li we produced a rapid and single 
tube multiplex assay (Xu et al.2005 30). The “holy grail” is to be able to determine 
individual genotypes without full sequencing so very large numbers of strains can be 
examined rapidly and cheaply.  When we designed our PCR assay we linked it to the 
technique used to detect single nucleotide polymorphisms (SNP) in cancer genotyping, 
denaturing high performance liquid chromatography (HPLC) (dHPLC).  I pioneered the 
use of dHPLC for PCR amplimer sizing for strain typing Mycobacterium tuberculosis in 
the 1990s, but now applied the hetroduplex ADS BIOTECH dHPLC WAVE methodology 
in this paper as proof of principle.  We went on to develop methods to cover all the 
commonly encountered CTM-X genotypes (Xu et al. 2007 31). We were the first to apply 
and validate this technology and have used it in many studies as have other groups.  It has 
the advantage that every new specific genotype encountered will produce a novel trace 
which following DNA sequencing can be added to the library. 
In parallel with my dHPLC WAVE approach I also developed a very different 
methodology for specific CTX-M genotyping based on the oligotyping was being used for 
strain typing of M. tuberculosis.  This involves generating a large number of specific 
oligonucleotide probes which can detect specific SNPs and immobilising them on a 
matrix.  The unknown field strain has a CTX-M specific PCR applied to it to generate 
single stranded segments of the bla CTX-M ORF which are also labelled during the PCR 
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process.  Depending on the SNP present, a unique probe binding pattern will be seen 
which translates into genotype.  This was the first time reverse-line hybridization was 
applied to β-lactamase characterisation (Ensor et.al 2007 8).  We used it for several years 
ultimately finding that dHPLC WAVE was cheaper and higher throughput. 
It is important in epidemiological studies to identify the genotype of the strain of E.coli or 
Klebsiella pneumonae carrying the CTX-M β-lactamase. Whilst Multi Locus Sequence 
Typing (MLST) is helpful in grouping key strains a more discriminatory method is 
needed. In the 2000’s this was pulse field gel electrophoresis (PFGE) as the use of whole 
genome sequencing to determine SNP type had not been introduced.  I was asked to 
collaborate with a Dutch group to explore the use of Raman spectroscopy for strain typing 
Klebsiella spp. We did identify some clusters by Raman spectroscopy using our collection 
of CTX-M producing K.pneumoniae from humans and chicken meat.  Although we 
identified new MLST types of K.pneumoniae many of the MLST types were grouped in 
the same Raman cluster.  We found a low level of discrimination, supporting the view  
that the method was not particularly useful (Overdest et al. 2014 26). 
2.3 Worldwide epidemiology of CTX-M ESBL (excluding UK and Asia) 
Identifying the threat of CTX-M β-lactamases in China long before they reached the UK 
stimulated me to take an interest in the worldwide distribution and incidence in these β-
lactamases. The most comprehensive global surveillance for resistant in E.coli and 
Klebsiella spp. is run by the Merck pharmaceutical company as the Study for Monitoring 
Antimicrobial Resistance Trends (SMART) worldwide study.  It supports a network of 
globally distributed hospital centres that every year collect Enterobacteriaceae from 
significant intra abdominal infections.  The isolates are forwarded to a central laboratory 
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using internationally recognised methodology to determine antibiotic susceptibilities and 
ESBL production. From time to time sample sets of data from an individual year in a 
global region are published.  I was invited with Professor Yeuda Carmeli to analyse the 
European data for 2008 and produce a paper (Hawser et al 2011 16).  This was the first 
time EUCAST break points were used for a published SMART study and the rapid rise of 
ESBLs in some countries such as Italy and the UK were identified. 
I was always struck by the occurrence of particular genotypes in certain regions e.g. CTX-
M14 in China, CTX-M-15 as the only genotype in India/Pakistan, CTX-M-3 in South 
America, CTX-M-1 in Poland, Russia and Italy/Libya.  A phylogenetic analysis suggested 
that the mobilization from Kluyvera spp chromosome happened twice for CTX-M-2, at 
least 3 times for CTX-M-whereas, CTX-M-9, CTX-M-8 and CTX-M-25 all only 
mobilised once (Barlow et al. 2008).  In a review I authored (Hawkey & Jones 200915) I 
advanced the hypothesis that an emergence in particular locations of CTX-M was 
favoured by high rates of antibiotic usage and poor health infrastructure (particularly 
sewage treatment).  The subsequent spread of those evolved genotypes was via the 
movement of people. I realised there are clear cultural/historical connections with some 
countries. e.g. India/UK; Italy/Libya. The widespread movement of the Chinese often 
carrying with them CTX-M-14 and people from India/Pakistan with CTX-M-15 seemed 
to be the driver for the global spread of the CTX-M genotypes.  The global pie chart of 
genotypes in that review became widely used by many lecturers and the review is one of 
the Journal Antimicrobial Chemotherapy’s top 10 cited papers of all time  
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In addition to the first recognition of CTX-M as the dominant ESBL in China 
(Chanawong et al 2002 5) and CTX-15 in India (Ensor et.al. 2006 9).  I have undertaken 
first genotyping surveys in two other countries.   
There was very little data on Arabian gulf countries so I was pleased to be able to 
collaborate with microbiologists in Kuwait. (Ensor et.al.2009 7).  We found the CTX-M-
15 genotype to be totally dominant (27/29 isolates only 2 CTX-M-9).  There are very 
large numbers of guest workers, largely from India and Pakistan.  We also found CTX-M 
ESBLs to be more common in non- Kuwaiti Arabs with a history of recent travel.  
Although very close geographically and culturally to the UK the first genotyping study in 
Ireland demonstrated some significant differences between the two countries (Morris et al. 
2009 21). A total of 812 isolates of Enterobacteriaciae from throughout Ireland were 
collected of which 506 from 462 patients were ESBL positive.  A single isolate from each 
patient was studied in more detail and all were subjected to PFGE analysis, a total of 
371/462 being positive by our PCR method for CTX-M.(Xu et.al 3005 30). Each PFGE 
type had a representative isolate genotyped by dHPLC for bla CTX-M genotype.  bla CTX-M15 
was found in 177 isolates, bla CTX-M-14  in 78 isolates and 3 isolates for bla CTX M-9 and a 
single bla CTX-M-1.  The occurrence of CTX-M14 was much higher than in the UK which 
may reflect the greater involvement of the population with beef and milk production.  In 
England CTX-M13 and 14 are roughly equally distributed in cattle Vetinary Laboratory 
Agency UK (VLA-unpublished data). 
2.4 Epidemiology of CTX-M in China & Asia. 
My work leading to the identification of CTX-M 14 and 13 in China was referred to 
earlier in this thesis and represents arguably one of the most important pieces of early 
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work on MRGNB in China (Chanawong et.al 2002 5). I was invited by the European 
Society of Clinical Microbiology and Infectious Diseases to be a faculty member at their 
first meeting on extended spectrum β lactamases in Venice in 2007.  They commissioned 
me to review all of the literature relating to ESBLs in Asia.  I presented my findings at the 
meeting and then produced a much condensed manuscript for publication (Hawkey 2008 
13).  My review of the situation in China showed that initially reports were confined to 
SHV-5, 2 and 9. The description of CTM-13 which was not found in any subsequent 
surveys was important as in the last few years it has begun to emerge as a significant 
genotype in some Chinese surveys. There were subsequent studies particularly the one by 
Yu and colleagues which showed that 14 was dominant with a smaller number of CTMX-
3 which we had found in some later studies particularly the one around Wuhan (Munday 
et.al 2004 24).  Interestingly Taiwan very much reflected the genotype distribution in 
China which bearing in mind the cultural and ethnic links could be explained by 
movement of population.  Japan and South Korea from genotype terms are very different 
to China which again may fit with the movement of population and interactions. The first 
descriptions of CTX-M were subsequently realised to be CTX-M group β lactamases 
when the widely distributed TOHO-1 and 2 were sequenced they seem to be confined to 
Japan.  They were subsequently given the designation CTX-M-44 and 45 respectively.  
TOHO-1 is very closely related to CTX-M-2, and subsequent surveys in Japan showed 
that CTX-M-2 is the dominant CTX-M genotype in Japan but the second most common 
type TOHO-2 (CTX-M-45) is a distant relative of CTX-M-9.  Korea has a similar picture 
to Japan but with more impact made by CTX-M-14 and remarkably a very small number 
of CTX-M-15 which in this period of time was more associated with India.  With regard 
to India the presence of phenotypically described ESBL’s had been recorded for a number 
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of studies since the 1990’s however, no one had genotyped isolates from that country.  I 
undertook the first study which showed only CTX-M-15 to be present at a very high rate 
(Ensor et.al 2006 9).  
Other Asian countries had very little data with the exception of Thailand where an earlier 
study by my group had demonstrated the presence of a single isolate carrying VEB-1 the 
dominant ESBL type were SHV ESBLs 5 and 12. (Chanawong et al. 2001) That latter 
study was from Khon Kaen in Northern Thailand with isolates collected in late 1994-1996 
and a study published on isolates from 2003 showed the presence of CTX-M-9 and CTX-
M-14 in addition to VEB (36% of ESBLs) in Southern Thailand(Chanawong et al. 2007). 
This presumably represents the spread into Thailand of Chinese and Vietnamase strains 
carried in the gut of travellers. Following our initial description of CTX-M-13, and 14 Dr 
Yusong Yu in Shanghai carried out a limited survey as did two separate groups in Beijing.  
They demonstrated probably because of the very small numbers of strains examined, 
CTX-M-3 together with CTX-M-14 in Beijing.  The opportunity arose to undertake a 
study on ESBLs from Wuhan which is geographically remote from the three major cities 
in China, being located in Central China.  This survey showed the presence of CTX-M-14 
but also that approximately 25% of the strains were CTX-M3 reinforcing the notion that 3  
also emerging in the Asia specific region and spread early on in the dissemination of 
CTX-M, ESBL’s. (Munday et.al 2004c 24). By the mid 2000’s there had been no English 
language published survey of resistance in MRGNB across China other than that written 
by myself and Dr Craig Munday (Munday et.al 2004 c 24) which summarised four 
published studies, which consisted of small published individual local city surveys and 
reported on a 5th larger survey in Wuhan.  I felt we needed a better handle on what was 
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going on in China with regards to the prevalence of CTX-M β-lactamases, particularly in 
the community.  I was able to persuade Merck to support a study of antimicrobial 
susceptibility of community isolates.  The majority were from urine or sputum from those 
already identified as community patients across 23 individual laboratories in 7 regions 
focused on Beijing, Guangzhou, Shanghai, Hong Kong and the Provinces of Hunan, 
Wuhan and Zhejiang between 2002 and 2003. A total of 2099 non duplicate clinical 
isolates were collected of which 1615 were Enterobacteriaceae.  (Ling et.al 2006 18). The 
953 E.coli isolates were collected from the community in which a resistance rate of 14.4 
% was seen to cefotaxime and 2.7% to ceftazidime, interestingly  the ciprofloxacin 
resistance rate was 50.6% and the gentamicin resistance rate was 39.4.%. This illustrates 
the high levels of resistance rates present in Chinese isolates, even in the early 2000’s.  In 
the case of Klebsiella spp. the cefotaxime resistance rate was 15.4% and 8.1% to 
ceftazidime.  The ciprofloxacin resistance rate was 25.2% which probably reflects the 
intensive use of quinolones in the community.  The less intensive use of quinolones in a 
hospital setting results in less selective pressure on Klebsiella spp. which is more 
associated but are there is wide spread availability in the community where E.coli is 
exposed to ciprofloxacin. A small sample of E.coli and Klebsiella spp. were subsequently 
checked by PCR for the presence of different genotypes when CTX-M-14 followed by 3 
were found to be the common genotypes (this data was never published). 
With the very high rate of CTX-M, ESBLs in China and the fact that our earlier study was 
from 1997 where we found CTX-M-14 was the dominant type it occurred to me that it 
would be helpful to have a detailed genotyping study on a large number of isolates from a 
large city other than Guangzhou.  We therefore initiated a project which involved three 
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major hospitals across Changsha the capital city of Hunan province, the city has a 
population of over 10 million people.  Between October 2004 and July 2005 425 non-
duplicate clinical isolates of Enterobacteriaceae were selected. (Liu et al. 2009 19). The 
overall ESBL rate was 33.4% (1424/425) and 109/142 were found to carry CTX-M; PCR 
dHPLC backed up by DNA sequencing was used to determine genotype.  47% were CTX-
M-14, 29.4%  were  CTX-M-3 but a great surprise was that 17.4% were CTX-M-15. This 
was the first report of CTX-M-15 in China and perhaps represented the importation from 
India of CTX-M-15 producing strains. CTX-M-15 was found in both E.coli, Klebsiella 
pneumoniae and Entrobacter cloacae suggesting there had been substantial spread in 
different bacterial hosts within the city. CTX-M-15 was also found in two of the three 
hospitals.  More recently, I was interested in whether or not CTX-M-15 had begun to take 
over from CTX-M-14 and CTX-M-3 in China and we undertook a further study between 
November 2013 and January 2014 across the whole of Hunan province by sampling from 
8 different geographical centres healthy subjects in the community that were submitting 
pre-employment faeces samples.(Zhong et.al 2015 33).  We sampled 563 subjects 287 of 
which (51.0%) carried ESBL producing E.coli all of which were CTX-M positive.  The 
genotype distribution was interesting: CTX-M-14 (48.4%), CTX-M15 (27.5%), CTX-
M27 (15.0%), the remaining 9.9% were made up small numbers of CTX-M 65, 24,3,104 
and 101. This study dramatically demonstrated the success of CTX-M-15 in displacing  
CTX-M-3 totally and reducing CTX-M-14, but also the rise of CTX-M-27 which more 
recently has been identified in Chinese pig herds.  This finding leads me to speculate that 
this may be a very important source of CTX-M genes for transfer into human adapted 
strains of E.coli. Interestingly, only 11.1% of the 287 CTX-M positive isolates belonged 
to the ST131 clone although one must bear in mind that this was a survey of healthy 
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individuals.  Within that clone the 016-ST131 isolates were dominant and contained the 
fimH41allele. The fimH genes encode type 1 fimbriae that enhance uropathogenicity. The 
most commonly encountered ST131 strains carry either fimH30, a genetic variant which is 
particularly associated with resistance to fluoroquinolones and production of CTX-M.  
The fimH41allele has only recently been identified and has not previously been associated 
with CTX-M production which was shown in our paper. The remaining isolates belonged 
to 025b, ST131. PFGE analysis showed that the ST131 isolates formed one large group at 
a 64% similarity level and could be further sub-divided. This study shows most 
importantly that 016-ST131 isolates have now emerged from China and form the 
predominant type of ST in faecal isolates of E.coli from healthy individuals carrying 
CTX-M.  At the time of writing this was the first study to identify 0.16-ST131 as the 
predominant type of a clonal group in a collection of ST 131 and this may presage the 
emergence of interesting potentially virulent clones in the general community within 
China. As mentioned in the earlier section on worldwide epidemiology ESBL producing 
Enterobacteriaceae had been long recognised phenotypically in India with reports from 
the end of the last century but no genotyping other than the very first report of CTX-M-15 
which involved the study of a small number of isolates in Paris which came from six 
Indian patients at the Betra Hospital , New Delhi (Karim et al. 2001)  ESBL rates reported 
in South Asia vary widely from 12-71% , but most studies reported a prevalence rate of 
around 50% and upwards.  I managed to identify an Indian collaborator in Aligarh who 
collected strains from 3 centres across India 111 isolates from Aligarh, 10, from Varanesi, 
9 from Karnataka S. India) and came to the UK to work under my supervision.  The 
dramatic finding he made was from further analysis of the 130 non duplicate clinically 
significant from E.coli and K pneumoniae isolate resistant to third generation 
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cephalosporins, was that 73% carried CTX-M and that they were all CTX-M-15 We 
undertook further analysis of these isolates looking at the location of IS26 and identified a 
number of variants suggesting that there has been considerable evolution over time of 
these genes of the genetic environment of the CTX-M-15 (Ensor et al.2006 9).  Our data 
which was the first systematic molecular large scale survey on characterizing CTX-M in 
India lends support to the belief that CTX-M-15 emerged in India sometime in the late 
1980’s and that it then dispersed across the world. 
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2.5 Epidemiology and occurrence of CTX-M in the UK 
In the course of undertaking routine surveillance whilst at the University of Leeds I 
discovered a single isolate from a six year old child in May 2000.  The isolate was from a 
routine stool screening sample from a haematology patient in which an ESBL phenotype 
Klebsiella oxytoca was recovered.  The MIC’s of cefotaxime were 32 mg/L and 
ceftazidime 4mg/L, which were consistent with an ESBL with marked cefotaximase 
activity.  PCR amplification and DNA sequencing revealed the presence of bla CTX-M-9.  
This was the first ever report of CTX-M in the UK.  Upon moving to Birmingham I 
maintained an interest in surveillance for CTX- ESBLs and as described previously was 
responsible for characterising isolates in an outbreak at the City Hospital caused by CTX-
M-26.  In September 2001 I had just moved to Birmingham and received a call from Dr. 
Rod Warren at Shrewsbury saying that he thought he had found 4 isolates of E.coli which 
were producing an ESBL and could I characterise them. We did this and discovered that 
two were both producing CTX-M-15.  We subsequently learnt that the isolates had also 
been sent to Colindale who had initially mis-sequenced them as a different genotype. We 
contacted the reference lab and asked them if they were absolutely certain of their 
sequencing and they rechecked and confirmed that our sequencing was correct.  These 
isolates subsequently were further characterised with others and published by the 
reference laboratory (Karisik et al. 2006).  It seemed to me that the bowel flora was the 
most important reservoir of these organisms both in the community and in hospital as it 
had been well established in outbreaks of Klebsiella pneumoniae in the late 1970s and 
1980s.  I therefore suggested that we should undertake a survey of faecal carriage in the 
general population.  The only readily accessible samples being those submitted from 
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patients with diarrhoea or GI illness.  We had a laboratory in York which wished to 
undertake a project on ESBL’s and they between October and December 2003 examined 
1000 consecutive, non- duplicate faeces samples of which 565 were from the community.  
I found an overall carriage rate of ESBL phenotype Enterobacteriaceae of 1.9% and 
interestingly identified five CTX-M-15, three CTX-M-14 and nine CTX-M-9 producing 
strains of Enterobacteriaceae confirming the importance of the faecal reservoir both in 
hospitals and in out-patients.  This was to my knowledge the first observation of CTX-M 
in faecal flora in the UK (Munday et.al 2004 23) In September 2004 the BSAC organised 
an extraordinary meeting to bring an awareness of the importance of CTX-M to the 
broader microbiology community.  I contributed to this meeting with our experience and 
also reported on my earlier work in Asia as well as reminding the audience that 
cefpodoxime as we had shown earlier is one of the best single substrates particularly when 
tested as the only cephalosporin on urinary isolates to ensure that ESBLs  were detected in 
all isolates of Enterobacteriaceae.  Together with Professor David Livermore we wrote a 
short review of that meeting which also contained some observations on the importance 
and the way in which CTX-M was beginning to dominate the UK microbiology scene. 
(Livermore and Hawkey 2005 20).  The earlier study referred to above on the CTX-M-15 
in the UK very much gave the impression that CTX-M-15 was the only important CTX-M 
and that this was strongly associated with ST131 lineage of E.coli. This was because 
many of the isolates came from a single hospital. Whilst we must accept that this is a most 
important clone, some of my informal surveillance activity suggested there was a greater 
diversity of both host E.coli and genotype of CTX-M circulating in the West Midlands.  
We were able to involve 13 different centers across the West Midlands region which has a 
population of approximately 6 million people. The laboratories for a period of two months 
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in 2006 collected 370 consecutive non duplicate isolates which were presumed to be 
ESBLs.  These were screened for the presence of CTX-M, genotyped and also 
differentiated by pulse field gel electrophoresis (Xu et.al 20011 32). We found that 96.6% 
of the isolates carried a CTX-M-15 with the remainder carrying most commonly CTX-M-
9 and 14. By using an ST131 specific PCR 66% of CTX-M positive isolates belonged to 
the ST 131 lineage.  Our PFGE analysis show that the largest number belonged to strain 
A.  Strain A was previously identified by Woodford and colleagues.  This was the first 
regional detailed epidemiological study of CTX-M in the UK and showed that there had 
been considerable spread of the bla CTX-M particularly of CTX-M-15 into non ST 131 
clones and that strain A was considerably more heterogeneous than when first described. 
We showed it had acquired a much higher level of gentamicin resistance probably by 
transposition of gentamicin resistance genes into the resident CTX-M plasmids. 
Approximately a third of the producers identified were unrelated strains suggesting that 
the genes had become dispersed rapidly in the Enterobacteriaceae over a 3 year period 
since the initial outbreak.  This study was undertaken between April and May 2006 just 3 
years after the first published report of the occurrence of CTX-M-15 in the UK.  
Following our work in India to identify a CTX-M-15 genotype, being the only CTX-M 
carried in that country, I wished to understand the degree of penetration by these genes 
into the local Birmingham population.  To go out and recruit individuals in the 
community, distribute individual questionnaires and obtain detailed information on them 
and then culture their faeces, would have required considerable funding which was not 
available at the time.  I therefore hit on the notion of using a computer database and 
programme called OriginsInfo which ascribes a cultural ethical and linguistic origin to an 
individual based on their name.  It has been validated and successfully used in a variety of 
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health care settings including cancer epidemiology and healthcare delivery audits.  We 
sampled stool samples from 732 individuals within the general community around 
Heartlands hospital in 2010 and screened them for ESBL production using chromogenic 
agar (Wickramsinghe et.al 2012 29). 
Their names were fed through the data base and described as either European origin, or 
Middleastern/South Asia (MESA) origin, a very small number of other groups such as 
Chinese and African were also identified.  The finding was very striking in that there was 
a statistically significant difference (p<0.001) in carriage in the European group (8.1% ) 
and the MESA group (22.8%).  There was also high rate of carriage of CTX-M-15 
producing E.coli in MESA subjects (p<0.001).  This was the first demonstration anywhere 
in the world that cultural and ethnic origins would result in differences in the rate of 
carriage of CTX-M ESBL producing E.coli across a single community. The findings were 
important and have been widely cited as this lends credence to the concept of the 
movement of people being the main driver for the spread of CTX-M across the world.  In 
a collaborative study with Professor Neil Woodford’s group at Colindale we sought 
funding for and were funded to look at the diversity of plasmids in ESBL E.coli and 
diversity of plasmid addiction systems by them carried by E.coli in the UK.  A large 
sample of plasmids were characterized in detail, interestingly quite a significant number 
48/118, could not be electroporated or transformed into a laboratory E.coli background 
suggesting that there was some degree of fixation of plasmids in particular host linages.  
We did manage to demonstrate that 70/118 plasmids were transformable and that this is an 
important route in the UK for the dissemination of CTX-M ESBLs.  We also wished to 
understand the nature of plasmid addiction systems and found a wide variety of addiction 
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systems which had not been appreciated in previous studies in the UK. (Doumith et.al 
2012 6). 
2.6  The environmental resistome in relation bla CTX-M 
The largest reservoir of Enterobacteriaceae carrying blaCTX-M  is the gut of mammals both 
human and food/companion/wild animals.  Faeces are discharged into the environment 
and the subsequent contamination of water, food and the environment is an important 
route for their spread and therefore a crucial area for control.  Antibiotics used in human 
and animal medicine/husbandary extert a variable selection as part of the transmission 
dynamics which are summarised in Figure 2.  The role of mobile elements in the 
resistome is also very important and I have a long standing interest in  this area. 
Group 9 CTX-M genes are most frequently associated with class one integrons which are 
complex structures enabling the expression of genes imported by horizontal gene transfer 
into bacteria that lack a potent promoter.   They also carry genes encoding resistance to 
quarternary ammonium compounds which I have always felt may act as a selection 
indirectly for antibiotic resistance gene cassettes contained within the class 1 integrons.   
There has been a lack of controlled studies demonstrating the impact of quaternary 
ammonium compounds, which are widely used as fabric softeners, detergents and in 
hospitals in disinfectants, on the carriage of class 1 integrons.  On moving to Birmingham 
I was able to establish a research collaboration with Professor Liz Wellington at the 
University of Warwick who is an environmental microbiologist and I suggested to her that 
we should undertake some environmental studies on the impact QACs have on the 
incidence of integrons and potential antibiotic resistance gene maintenance.  
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Figure 2. Principle transfer pathways for antibiotic resistance genes in humans, animals, 
food and the environment. (Reproduced with permission from The Joint Work Group 
Defra’s Antimicrobial Resistance Co-operation (DARC) and Advisory Committee on 
Antimicrobial Resistance and Healthcare Associated Infections (ARHAI) ESBLs.  A 
threat to human and animal health? 
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 I previously worked in Yorkshire where I had access to a fabric finishing mill which used 
large quantities of QACs (1-.2% of the fabric weight processed), which was then  
discharged into a large treatment system using reed beds, before finally being discharged 
into the river Aire.(Gaze et al 2005)  
We were able to set up a study whereby we sampled river sediment and water at all of the 
relevant parts of the mill and reed bed system including the outlet to the sewage works 
and river. No antimicrobials or human sewage were passed into this system.  
This study was the first time we were able to demonstrate that the level of occurrence of 
class 1 integrons was very high compared to other less contaminated environmental sites 
such as farm soil and relatively pristine water courses. (Gaze et al. 2005 10).  As part of 
our continuing collaboration we went on to later study the effect of quarternary 
ammonium compounds in a variety of agricultural wastes, de-watered sewage sludge and 
soils.  For the first time we were able to demonstrate the impact that amended sludge 
containing low levels of antimicrobials in an agricultural environment has on the 
prevalence of class one integrons.  Again we demonstrated a substantial increase in 
integron carriage rates which in turn would enable those bacteria to acquire resistance 
cassettes on exposure to other bacterial strains with transferable antimicrobial resistance. 
(Gaze et al 2011 11)  
As a result of my work on faecal carriage in particular ethnic groups in Birmingham I 
decided it would be interesting to embark on a study of sewage effluent and the effect of 
modern sewage treatment on the persistence of bla CTX-M genes in the effluent from 
sewage treatment works.  The only previous study in river waters was one which did not 
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find bla CTX-M-15  and only found a very low frequency of occurrence of bla CTX-M-14  
(Dhanji et al. 2011).  Working with my collaborator Liz Wellington and a joint post doc, 
Dr Will Gaze, I suggested that we look at the sewage works serving Coventry which takes 
all of the domestic and industrial sewage from that city which has quite a high level of 
ethnic diversity with a large Bangladeshi population (Amos et al 2014 2) .  We looked at 
three sampling points upstream of the sewage works and three sampling points down 
stream of the sewage works at 300, 600 and 900 metre intervals.  The treatment plant 
serves approximately 500,000 people and processes 120 million litres of raw sewage per 
day using primary, secondary and tertiary treatments.  We demonstrated there was a 
highly statistically significant difference in counts of E.coli producing CTX-M 
downstream compared to upstream of the discharge point.  The genes we recovered were 
largely bla CTX-M-15 as might be expected from our work of faecal carriage and the 
diversity of the population served by this works.  What was particularly concerning was 
the very high rate of the isolation of both E.coli and using metagenomic methods, a 
diversity of environments for the blaCTX-M  particularly in the non culturable microbiome.  
We also found in the exogenous isolated Enterobacteriaceae that a large number of 
rearrangements compared to those normally seen in clinical strains environment for CTX-
M-15 were identified.  This leads me to believe that the act of sewage treatment puts a 
severe pressure  (physiological and antimicrobial) on the genes in the microbial 
environment of the sewage leading to genetic re-arrangements, some of which may be 
more easily dispersed than the parental types.  This was the first study to show the 
importance of the dissemination of CTX-M through sewage treatment works.  (Amos et al 
2014a  2)  We went on to undertake a much more detail metagenomic library analysis of 
the river course from the previous study and were able to demonstrate a huge diversity of 
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evolution of particularly aminoglycoside inactivating genes but also β-lactamase genes, 
further supporting the impact that sewage works have on releasing antibiotic resistance 
genes into the environment following treatment in waste water treatment plants.  (Amos et 
al 2014 b 3).  I suggested to Professor Liz Wellington that it would be a good idea to bring 
some of our data and other workers data to the attention of the medical community 
because of the increasing interest in antimicrobial resistance. She agreed and she first 
authored with myself and a number of others a highly cited review paper to which I 
contributed all of the medical and CTX-M commentary and data. (Wellington et al 2013 
28). 
2.7 CTX-M β-lactamases and their occurrence in food 
E.coli particularly and to and lesser extent Klebsiella pneumoniae carrying CTX-M are 
found in the gut of humans from when they can have acquired them by ingestion from 
environmental contamination but also potentially from contaminated food. The wide 
spread use of modern intensive agriculture, particularly for poultry and fish production, 
with the extensive use of antimicrobials is a now a well- recognised threat to the control of 
antimicrobial resistance. During my visits to China in the early 2000s I had discussions 
with their State Drug Administration and it became clear that very large amounts of 
antimicrobials were being used in both poultry and fish production in China. Talking to 
other vets and experts as a result of my membership of the Department for Environment 
Food and Rural Affairs (DEFRA) Antimicrobial Resistance Committee I suggested that 
surveillance should be instituted for CTX-M genes by the Veterinary Medicines 
Directorate (VMD) in England. This surveillance was instituted in the late 2000s and 
interestingly found in dairy cattle and subsequently in poultry and pigs the presence of 
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surprisingly high levels of CTX-M β-lactamase producing E.coli.   In dairy cattle the 
predominant genotype of CTX-M was CTX-M-14 and whereas in chicken initially only 
low levels of CTX-M-1 were found, this has increased more recently.  I decided it would 
be valuable to undertake a survey particularly of imported chicken meat as well as UK 
produced meat as my knowledge of the characteristic genotype distribution of CTX-M 
might give a clue and/or correlate with the source of the imported chicken meat. I 
collaborated with Dr Rod Warren in the public health laboratory in Shrewsbury and 
together we collected 129 fresh and frozen chicken breast fillets from retail outlets and 
processed them for the presence of CTX-M ESBLs. Of the 62 UK reared chicken samples 
only 1 yielded CTX-M producing E.coli which was a CTX-M-1 producing E.coli.  In 
contrast 4 of the 10 Brazilian samples produced CTX-M-2 which is the genotype most 
frequently encountered in that part of the world and we also had 2 Dutch samples 
producing CTX-M-2.  We identified 5/40 unknown samples of chicken meat which had 
been processed at a minimum of 2  UK cutting stations, our suspicions being that this had 
been raised potentially in Thailand, by extrapolation of the presence of CTX-M-14. This 
was the first study to demonstrate that chicken meat may represent an important source for 
the movement of CTX-M genes around the globe. (Warren et al 2008 27). 
As a consequence of our publication I was contacted by a Dutch group who were also 
interested in doing a comprehensive study of a small town in Holland to ascertain what 
the distribution was amongst food samples, clinically significant infections and faecal 
carriage in the normal population with regard to CTX-M genotypes and sequence type of 
E.coli. Our study (Overdevest et al 2011 25) proved to be a seminal work demonstrating 
the same genotypes that were most common in the normal population in the towns studied 
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were present in the chicken and other meat and caused bacterial infections. CTX-M-1 was 
also the dominant (58.1% ) genotype in chicken samples available in retail centres.  The 
same genotype was also responsible for 28% of bacteremia in the same town. Whilst we 
could not make an absolute link between the individual strains this study stimulated an 
enormous interest both in the Netherlands and elsewhere and has driven further more 
detailed studies, one of which from Flagstaf Arizona was presented in preliminary form at 
ECMID 2016 suggests that about 15% of all urinary tract infections arise from the 
consumption of meat carrying human pathogenic E.coli.  
My detailed understanding from many visits to China of the use of antibiotics there has 
led me to establish a collaboration with the College of Vetinary Medicine at the South 
China Agricultural University in Guangzhou to study the occurrence of CTX-M 
producing E.coli in Chinese farmed fish.  Fish meat in China is often very lightly cooked 
and carries significant numbers of E. coli at the point of consumption. Therefore is likely 
to be a good vector for disseminating bla CTX-M, and/or other multi resistance strains of 
MRGNB.  I therefore decided to design a study with Dr Hong-Xia Jiang to look at retail 
fish prior to consumption for both the presence of bla CTX-M and plasmid mediated 
quinolone resistance.  It is my impression from talking to experts in the Ministry of Health 
in China that large amounts of quinolones are used in fish production and not third 
generation cephalosporins.  There is also little or no sewage contamination of fish farms 
as there are separate means available for the disposal of human sewerage.  We found 
relatively low numbers of bla CTX-M but all of the genotypes seen frequently in the Chinese 
population ie. bla CTX-M-14 and bla CTX-M-79., 19/112 strains carried ESBL genes. We did 
however, find very high rates of Plasmid Mediated Quinolone Resistance (PMQR), 
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identifying these genes in 59/80 strains picked from non-selective media.  This was the 
first study to demonstrate the existence in farmed fish in China of high levels of PMQR 
genes as well as the presence of bla CTX-M ESBL genes.  The study will be an important 
indicator of the considerable selective impact that the use of antimicrobials in fish farming 
will potentially have on human carriage of CTM producing E.coli. Hopefully this and 
other studies will lead to a change in policy. 
2.8 Conclusions and future work 
I have been fortunate in being responsible for the first identification in 1997 in China of 
CTX-M-14, one of the world’s most important ESBLs.  Prior to that time CTX-M - 
lactamases were seen as one of the many minority ESBL types, although they were 
recognised as important in South America.  It quickly became clear to me and my Chinese 
collaborator that because about 30% of E.coli in the survey we undertook in Guangzhou 
were cefotaxine resistant, with an ESBL phenotype, that this was a very important 
observation.  We reasoned that the fact that CTX-M-14 was plasmid mediated and 
transferable and that examination of a small number of isolates from Beijing and Shanghai 
showed the same genes, that this resistance marker was spread at high frequency across 
the whole of China.  The success of this resistance coupled with its frequent carriage in 
isolates of E.coli and other Enterobacteriaciae that are multiply antibiotic resistant 
suggested a potential for worldwide spread. This prompted us to look in the UK and 
whilst in Leeds we only found a single CTX-M-9 carrying isolate in 2003.  We 
subsequently uncovered the beginning of the UK endemic of CTX-M ESBLs which we 
discovered was caused by CTX-M-15.  This in turn suggested that India was likely to be 
the source, particularly as some of our earliest cases were from South Asia.  The first 
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survey for CTX-M in India confirmed our worse fears with very high rates of CTX-M 
both in clinical isolates and faecal carriage in the general population.  This demonstrated 
that there was a global pandemic.  The most important consequence of this pandemic was 
the increased usage of carbapenem antibiotics and the emergence of carbapenemases.  My 
work focussed on improving detection and molecular characterisation methods to enable 
us to understand the global epidemiology.  This provides basic information to design 
control strategies and ultimately control and hopefully reduce the frequency of CTX-M 
ESBLs.  We will see a lower usage of carbapenems and maybe reductions in 
carbapenemase producing Enterobacteriaceae. 
The consequences of the rise in CTX-M ESBLs, in terms of the environmental resistance 
are potentially huge.  Unlike MRSA multiply antibiotic resistant Enterobacteriaciae have 
a number of ecological niches in the mammalian gut and water courses.  It is also 
apparent, that they can survive in soils and the phytosphere, particularly when carried by 
Klebsiellae.  This has an irony in that the CTX-M gene was almost certainly mobilized  
from the Kluyvera spp. chromosome in the rhizosphere as Kluyvera spp. are the most 
important phosphate solubilizing bacteria.  This widespread contamination of many 
environmental niches with CTX-M genes creates a huge reservoir of genes to be further 
distributed back to humans and food animals.  I encapsulated this circulation in a diagram 
(Figure2) which I produced for a joint report on ESBLs for ARHAI and DEFRA. 
Future research is needed to more accurately delineate the size and complexity of human 
colonisation and environmental reservoirs.  As our work on sewage has shown both 
amplification and release into the environment of CTX-M genes and their host plasmids 
following even high level treatment.  Further work to reduce this contamination is 
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urgently needed. If we can identify novel strategies to eliminate plasmid carriage or the 
host E.coli this would reduce the reservoir of CTX-M in healthcare settings and 
potentially reduce transmission.  Finally the development of novel alternative agents will 
reduce the pressure to use both third generation cephalosporin antibiotics and 
carbapenems. 
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